Trials / Completed
CompletedNCT05560412
Zein Nanoparticles for Glycemic Control
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Clinica Universidad de Navarra, Universidad de Navarra · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The use of zein nanoparticles as vehicles for drug delivery is under study, but of the effects observed in empty nanoparticles, in laboratory animals, the reduction of glucose levels was something worth studying. Thus, the present research on patients with prediabetes has been proposed. The objective is to assess the efficacy of zein nanoparticles on the glycemic control. For this purpose, a randomized, double blind crossover study has been designed. Target sample size is 60.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Zein nanocapsules | 1 g of Zein nanoencapsulated daily |
| DIETARY_SUPPLEMENT | control | 1 g of Zein non-encapsulated daily |
Timeline
- Start date
- 2023-01-10
- Primary completion
- 2023-12-19
- Completion
- 2023-12-19
- First posted
- 2022-09-29
- Last updated
- 2024-01-31
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05560412. Inclusion in this directory is not an endorsement.